Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Velu

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Pathology, Research and Practice|June 1, 1995
A case of pleomorphic T-cell lymphoma with a high content of reactive histiocytes presented with hypereosinophiliaJ L Dargent, D Jacobovitz, O Pradier, et al.
Transplantation Proceedings|February 1, 1993
In vivo induction of IL-10 by anti-CD3 monoclonal antibody in miceT Velu, P Durez, M Van Mechelen, et al.
The British Journal of Ophthalmology|November 26, 2002
Retinal pigment epithelial cells phagocytosis of T lymphocytes: possible implication in the immune privilege of the eyeF Willermain, L Caspers-Velu, B Nowak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1995
In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptorS Fichelson, I Vigon, I Dusanter, et al.
European Journal of Immunology|December 1, 1993
TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune diseaseA Saoudi, J Kuhn, K Huygen, et al.
Immunodeficiency|January 1, 1993
Helper T cell dysfunctions in a patient with Omenn's syndrome: modulation by IFN-gamma therapyL Schandené, F Mascart-Lemone, A Ferster, et al.
Transplantation Proceedings|October 1, 1993
Role of the TH1-TH2 balance in the development of autoimmunity in ratsA Saoudi, J Kuhn, K Huygen, et al.
Investigative Ophthalmology & Visual Science|September 28, 2000
Role and expression of CD40 on human retinal pigment epithelial cellsF Willermain, L Caspers-Velu, N Baudson, et al.
Cytotherapy|April 30, 2010
Generation of immature autologous clinical grade dendritic cells for vaccination of cancer patientsM Toungouz, C Quinet, E Thille, et al.
Cancer Gene Therapy|December 1, 1995
Vectors in cancer therapy: how will they deliver?M Blaese, T Blankenstein, M Brenner, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Pathology, Research and Practice|June 1, 1995
A case of pleomorphic T-cell lymphoma with a high content of reactive histiocytes presented with hypereosinophiliaJ L Dargent, D Jacobovitz, O Pradier, et al.
Transplantation Proceedings|February 1, 1993
In vivo induction of IL-10 by anti-CD3 monoclonal antibody in miceT Velu, P Durez, M Van Mechelen, et al.
The British Journal of Ophthalmology|November 26, 2002
Retinal pigment epithelial cells phagocytosis of T lymphocytes: possible implication in the immune privilege of the eyeF Willermain, L Caspers-Velu, B Nowak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1995
In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptorS Fichelson, I Vigon, I Dusanter, et al.
European Journal of Immunology|December 1, 1993
TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune diseaseA Saoudi, J Kuhn, K Huygen, et al.
Immunodeficiency|January 1, 1993
Helper T cell dysfunctions in a patient with Omenn's syndrome: modulation by IFN-gamma therapyL Schandené, F Mascart-Lemone, A Ferster, et al.
Transplantation Proceedings|October 1, 1993
Role of the TH1-TH2 balance in the development of autoimmunity in ratsA Saoudi, J Kuhn, K Huygen, et al.
Investigative Ophthalmology & Visual Science|September 28, 2000
Role and expression of CD40 on human retinal pigment epithelial cellsF Willermain, L Caspers-Velu, N Baudson, et al.
Cytotherapy|April 30, 2010
Generation of immature autologous clinical grade dendritic cells for vaccination of cancer patientsM Toungouz, C Quinet, E Thille, et al.
Cancer Gene Therapy|December 1, 1995
Vectors in cancer therapy: how will they deliver?M Blaese, T Blankenstein, M Brenner, et al.
Pageof 10